scispace - formally typeset
H

Harshita Sharma

Researcher at Jamia Hamdard

Publications -  11
Citations -  421

Harshita Sharma is an academic researcher from Jamia Hamdard. The author has contributed to research in topics: Drug delivery & Functional food. The author has an hindex of 6, co-authored 10 publications receiving 313 citations. Previous affiliations of Harshita Sharma include Hamdard University.

Papers
More filters
Journal ArticleDOI

Metal nanoparticles: a theranostic nanotool against cancer.

TL;DR: Metal nanoparticles are proposed as one of the most promising theranostic agents for the treatment of cancer, and have potential as anticancer agents, either inherently or as a result of surface modifications.
Journal ArticleDOI

Bioadhesive polymers: novel tool for drug delivery.

TL;DR: The current review is an attempt to throw some light on the basics of the mucoadhesion: the mechanism of bioadhesion and the polymers that are used in the design of the bioadhesive delivery system with their properties that affect theBioadhesion.
Journal ArticleDOI

Development and characterization of metal oxide nanoparticles for the delivery of anticancer drug.

TL;DR: It can be concluded that zinc oxide nanoparticles loaded with DOX resulted in better uptake of the chemotherapeutic agent, and at the same time, showed low toxicity towards normal cells.
Book ChapterDOI

Bionanocomposites: smart biodegradable packaging material for food preservation

TL;DR: This chapter deals with methods of preparation of polymeric nanocomposites, types and properties of nanoreinforcements, and details of few important biodegradable polymers that are commonly used for preparing nanocomPOSites for food packaging purposes.
Journal ArticleDOI

Synergistic anticancer efficacy of Bendamustine Hydrochloride loaded bioactive Hydroxyapatite nanoparticles: In-vitro, ex-vivo and in-vivo evaluation.

TL;DR: The present work evaluates the synergistic anticancer efficacy of bioactive Hydroxyapatite (HA) nanoparticles (HA NPs) loaded with Bendamustine HCl and indicates a possible synergism between the activity of the anticancer drug and calcium ions derived from the carrier.